Sridharan V, Saravanan S, Muthusubramanian S, Sivasubramanian S. NMR investiga-
tion of hydrogen bonding and 1,3-tautomerism in 2-(2-hydroxy-5-substituted-aryl)
benzimidazoles. Magn Reson Chem 2005;43(7):551–556.
Valente AP, Miyamoto CA, Almeida FC. Implications of protein conformational
diversity for binding and development of new biological active compounds. Curr
Med Chem 2006;13(30):3697–3703.
Wilson SR, Malerd H, Petersen D, Simic N, Bobu MM, Rise F, Lundanes E, Greibrokk
T. Controlling LC–SPE–NMR systems. J Sep Sci 2006;29(4):582–589.
Xu F, Alexander AJ. The design of an on-line semipreparative LC–SPE–NMR system
for trace analysis. Magn Reson Chem 2005;43(9):776–782.
Yang Z. Online hyphenated liquid chromatography–nuclear magnetic resonance
spectroscopy–mass spectrometry for drug metabolite and nature product analysis.
J Pharm Biomed Anal 2006;40(3):516–527.
Zartler ER, Shapiro MJ. Protein NMR-based screening in drug discovery. Curr Pharm
Des 2006;12(31):3963–3972.
Zhang D, Zhao W, Roongta VR, Mitroka JG, Klunk LJ, Zhu M. Amide N-
glucuronidation of MaxiPost catalyzed by UDP-glucuronosyltransferase 2B7 in
humans. Drug Metab Dispos 2004;32:545–551.
Zhou CC, Hill DR. The keto–enol tautomerization of ethyl butylryl acetate studied by
LC–NMR. Magn Reson Chem 2006;45(2):128–132.
REFERENCES 409